Directly observed therapy at opioid substitution facilities using sofosbuvir/velpatasvir results in excellent SVR12 rates in PWIDs at high risk for non-adherence to DAA therapy

BACKGROUND & AIMS: We evaluated the effectiveness of sofosbuvir/velpatasvir (SOF/VEL) in difficult-to-treat PWIDs with presumed high risk for non-adherence to antiviral therapy using an innovative concept involving their opioid agonist therapy (OAT) facility. METHODS: N = 221 patients (m/f: 168/...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidbauer, Caroline, Schwarz, Michael, Schütz, Angelika, Schubert, Raphael, Schwanke, Cornelia, Gutic, Enisa, Pirker, Roxana, Lang, Tobias, Reiberger, Thomas, Haltmayer, Hans, Gschwantler, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177501/
https://www.ncbi.nlm.nih.gov/pubmed/34086708
http://dx.doi.org/10.1371/journal.pone.0252274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177501/
https://www.ncbi.nlm.nih.gov/pubmed/34086708
http://dx.doi.org/10.1371/journal.pone.0252274

Ejemplares similares